IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo (Q40544239)

21 September 2017

IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo (English)

1 reference

21 September 2017

9

Curie Ahn

1 reference

21 September 2017

Seung-Eun Choi

1

1 reference

21 September 2017

Kyung-Mi Choi

2

1 reference

21 September 2017

Il-Hee Yoon

3

1 reference

21 September 2017

Jin-Young Shin

4

1 reference

21 September 2017

Jung-Sik Kim

5

1 reference

21 September 2017

Woong-Yang Park

6

1 reference

21 September 2017

Duck-Jong Han

7

1 reference

21 September 2017

Song-Chul Kim

8

1 reference

21 September 2017

Jae-Young Kim

10

1 reference

21 September 2017

Eung-Soo Hwang

11

1 reference

21 September 2017

Chang-Yong Cha

12

1 reference

21 September 2017

Gregory L Szot

13

1 reference

21 September 2017

Kun-Ho Yoon

14

1 reference

21 September 2017

Chung-Gyu Park

15

1 reference

21 September 2017

language of work or name

1 reference

1 June 2004

1 reference

21 September 2017

Transplant Immunology

1 reference

21 September 2017

13

1 reference

21 September 2017

43-53

1 reference

21 September 2017

1

1 reference

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Contribution of adenoviral-mediated superoxide dismutase gene transfer to the reduction in nitric oxide-induced cytotoxicity on human islets and INS-1 insulin-secreting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Oxygen free radical scavengers protect rat islet cells from damage by cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

IL-6/BSF2 in normal and abnormal regulation of immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Multiple actions of interleukin 6 within a cytokine network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. An effect distinct from that of interleukin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

7 January 2021

Interleukin 6 (IL-6).

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

MTT-assay and neutral red release (NRR)-assay: relative role in the prediction of the irritancy potential of surfactants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine beta-cell damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Variance stabilization applied to microarray data calibration and to the quantification of differential expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Cytokine-induced apoptosis and necrosis are preceded by disruption of the mitochondrial membrane potential (Deltapsi(m)) in pancreatic RINm5F cells: prevention by Bcl-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Interleukin-lβ-Induced Nitric Oxide Production in Isolated Rat Pancreatic Islets Requires Gene Transcription and May Lead to Inhibition of the Krebs Cycle Enzyme Aconitase*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Pancreatic beta-cell death, regeneration and insulin secretion: roles of poly(ADP-ribose) polymerase and cyclic ADP-ribose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Lack of expression of Gp-130 makes pancreatic beta cell lines unresponsive to the IL-6 family of cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.04.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRIM.2004.04.001

1 reference

21 September 2017

1 reference